CN Patent

CN102688210A — 鲁拉西酮的药物组合物和制备方法

Assigned to Individual · Expires 2012-09-26 · 14y expired

What this patent protects

本发明公开了鲁拉西酮的药物组合物和制备方法。该鲁拉西酮药物组合物，其包括：式(I)所示鲁拉西酮、糖醇、崩解剂、粘合剂、和表面活性剂，以及任选的水不溶性填充剂。本发明鲁拉西酮药物组合物，其表面与水的接触角不大于95度。本发明鲁拉西酮的制剂特别是片剂不但具有良好的释放性能，而且还具有良好的机械性能。

USPTO Abstract

本发明公开了鲁拉西酮的药物组合物和制备方法。该鲁拉西酮药物组合物，其包括：式(I)所示鲁拉西酮、糖醇、崩解剂、粘合剂、和表面活性剂，以及任选的水不溶性填充剂。本发明鲁拉西酮药物组合物，其表面与水的接触角不大于95度。本发明鲁拉西酮的制剂特别是片剂不但具有良好的释放性能，而且还具有良好的机械性能。

Drugs covered by this patent

lurasidone-hydrochloride (LURASIDONE HYDROCHLORIDE)

Patent Metadata

Patent number: CN102688210A
Jurisdiction: CN
Classification: —
Expires: 2012-09-26
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.